All sponsors

GeneCradle Inc

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-31
RECRUITING4
READOUTS ≤12 MONTHS3
READOUT SLIPPED >6 MO67%

Delay Index: of 6 active trials registered more than a year ago, 4 have moved their primary completion (readout) date by more than 6 months since first registration (median +12.0 months). See all sponsors →

Open GeneCradle Inc on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
GC301
NCT05793307
P1/2Active, not recruitingPompe Disease Infantile-Onset162025-12-31 (+13 mo)
GC301
NCT06391736
P1/2RecruitingPompe Disease (Late-onset)332026-12
GC101
NCT05824169
P1/2RecruitingSpinal Muscular Atrophy182026-12 (+12 mo)
GC101 adeno-associated virus injection
NCT06971094
P3Active, not recruitingSMA - Spinal Muscular Atrophy502026-12-31
GC310
NCT07173933
P1/2RecruitingWilson Disease152027-12 (+8 mo)
GC101
NCT06421831
P1/2RecruitingSpinal Muscular Atrophy Type 3212027-12 (+12 mo)